MDxHealth (MDXH) FCF Margin (2023 - 2026)

MDxHealth (MDXH) posted FCF Margin of 27.99% for Q1 2026, up 372.58% sequentially from 10.27% in Q3 2025, and up 714.0% YoY from 3.44% in Q1 2025.

MDxHealth (MDXH) FCF Margin (2023 - 2026) Analysis & Trends

MDxHealth has reported FCF Margin for 4 years, with the latest figure at 27.99% in Q1 2026.

Quarterly FCF Margin rose 714.0% year-over-year to 27.99% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.25% (up 481.0% YoY) and the FY2025 annual result came in at 14.43%, up 1434.0% from the prior year.
FCF Margin grew to 27.99% in Q1 2026 per MDXH's latest filing, from 10.27% in the prior quarter.
Over five years, FCF Margin peaked at 27.99% in Q1 2026 and troughed at 59.3% in Q1 2023.
A 4-year average of 16.35% and a median of 18.18% in 2025 frame the typical range for FCF Margin.
The sharpest annual moves came in 2025 and 2026: FCF Margin soared 1496 bps in 2025, then surged 714 bps in 2026.
Over 4 years, FCF Margin stood at 46.24% in 2023, then surged by 41 bps to 27.45% in 2024, then jumped by 63 bps to 10.27% in 2025, then jumped by 373 bps to 27.99% in 2026.
According to Business Quant data, FCF Margin over the past three periods registered 27.99%, 10.27%, and 11.13% for Q1 2026, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	13.97%
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	20.19%
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	26.51%
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	10.95%
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	8.24%
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	2.59%
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	13.89%
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	27.51%
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	15.08%
10	MDxHealth	21.81 Mn	-21.34 Mn	16.61 Mn	27.99%

Download Data